CBS 2019
CBSMD教育中心
中 文

肺动脉高压

Abstract

Recommended Article

Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension? Pulmonary hypertension is associated with an increased incidence of NAFLD: A retrospective cohort study of 18,910 patients Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells Is the Cell of Origin for Occlusive Pulmonary Vascular Lesions. The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial

Expert Opinion2019 Feb 11;12(3):285-288.

JOURNAL:JACC Cardiovasc Interv. Article Link

Pulmonary Artery Denervation: A New, Long-Awaited Interventional Treatment for Combined Pre- and Post-Capillary Pulmonary Hypertension?

Dimopoulos K, Ernst S, McCabe C et al. Keywords: ablation; diastolic dysfunction; pre- and post-capillary pulmonary hypertension; pulmonary artery denervation

LINK

Please click on the "Article Link" on top right to get further access to this Editorial Comment.